[HTML][HTML] Invited Expert Opinion-Bioinformatic and Limitation Directives to Help Adopt Genetic Addiction Risk Screening and Identify Preaddictive Reward …

K Blum, MS Gold, JL Cadet… - Medical research …, 2023 - ncbi.nlm.nih.gov
Addiction, albeit some disbelievers like Mark Lewis [1], is a chronic, relapsing brain disease,
resulting in unwanted loss of control over both substance and non-substance behavioral …

[PDF][PDF] Allele frequency and genotype distribution of the opioid receptor µ-1 (OPRM1) A118G polymorphism in the Western Saudi population.

AM Bagher, RH Hareeri - Journal of Applied Biomedicine, 2023 - jab.zsf.jcu.cz
The single nucleotide polymorphism (SNP) A118G (rs1799971) in the Mu Opioid Receptor 1
(OPRM1) gene is associated with significant variations in analgesic doses and adverse …

Neurotoxicity in psychostimulant and opiate addiction

E Niedzielska-Andres, B Rospond… - Handbook of …, 2023 - Springer
Psychostimulants and opioids evoke toxicity within the central nervous system (CNS),
primarily linked to action of the substance (eg, enhancement of synaptic concentrations of …